DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Halozyme Therapeutics
HALO
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -14.84%36.41M | -26.94%38.93M | -1.73%40.6M | -9.25%189.7M | -13.56%52.35M | -9.21%42.75M | -7.61%53.29M | -5.47%41.32M | 85.95%209.02M | 6.84%60.56M |
Operating revenue | -14.84%36.41M | -26.94%38.93M | -1.73%40.6M | -9.25%189.7M | -13.56%52.35M | -9.21%42.75M | -7.61%53.29M | -5.47%41.32M | 85.95%209.02M | 6.84%60.56M |
Cost of revenue | -18.57%33.24M | 50.69%71.12M | 0.30%42.81M | 3.01%199.79M | 32.23%69.09M | -13.86%40.83M | -4.22%47.2M | -5.23%42.68M | 106.08%193.95M | 18.40%52.25M |
Gross profit | 64.29%3.16M | -628.64%-32.19M | -61.73%-2.21M | -166.95%-10.09M | -301.41%-16.74M | 722.65%1.92M | -27.49%6.09M | -2.71%-1.36M | -17.61%15.07M | -33.79%8.31M |
Operating expense | -4.28%36.88M | 9.28%59.57M | -7.40%47.18M | -22.71%191.7M | -6.47%47.61M | -33.00%38.53M | -23.73%54.51M | -25.24%50.95M | 27.74%248.03M | -29.26%50.91M |
Selling and administrative expenses | 40.42%25.38M | 20.90%36.67M | -1.58%27.37M | -29.47%106.61M | -15.59%27.34M | -48.54%18.08M | -24.35%30.33M | -36.14%27.81M | 19.93%151.16M | -34.77%32.39M |
-Selling and marketing expense | -5.80%8.05M | 226.65%25.8M | 16.09%11.15M | -40.76%40.33M | -0.46%11.74M | -47.24%8.55M | -61.29%7.9M | -51.21%9.61M | 41.87%68.09M | -36.01%11.79M |
-General and administrative expense | 81.88%17.33M | -51.55%10.87M | -10.91%16.22M | -20.22%66.27M | -24.25%15.6M | -49.65%9.53M | 13.93%22.43M | -23.70%18.2M | 6.44%83.07M | -34.04%20.59M |
Research and development costs | -43.78%11.5M | -19.22%17.14M | -14.39%19.81M | -12.16%85.1M | 9.46%20.27M | -8.61%20.46M | -32.35%21.22M | -5.94%23.14M | 42.19%96.88M | -16.99%18.52M |
Depreciation amortization depletion | ---- | 94.86%5.76M | ---- | ---- | ---- | ---- | --2.96M | ---- | ---- | ---- |
-Depreciation and amortization | ---- | 94.86%5.76M | ---- | ---- | ---- | ---- | --2.96M | ---- | ---- | ---- |
Operating profit | 7.88%-33.72M | -89.50%-91.76M | 5.60%-49.39M | 13.38%-201.79M | -51.07%-64.35M | 36.69%-36.61M | 23.23%-48.42M | 24.70%-52.32M | -32.46%-232.96M | 28.30%-42.6M |
Net non-operating interest income expense | -4.88%-1.46M | -48.95%-1.77M | -229.59%-2.91M | 68.69%-3.16M | 187.01%308K | 40.86%-1.39M | 78.98%-1.19M | 48.75%-882K | 15.81%-10.08M | 95.92%-354K |
Non-operating interest income | --228K | ---- | ---- | --944K | ---- | ---- | ---- | ---- | ---- | ---- |
Non-operating interest expense | 21.23%1.69M | 48.95%1.77M | 229.59%2.91M | -59.33%4.1M | 79.66%636K | -40.86%1.39M | -78.98%1.19M | -49.69%882K | -15.81%10.08M | -95.92%354K |
Other net income (expense) | -9,762.89%-9.57M | 75.66%-121.43M | 58.07%-112.92M | -8.51M | 99.96%-97K | -507.13%-498.8M | -269.3M | |||
Special income (charges) | --0 | -9,762.89%-9.57M | ---- | 75.66%-121.43M | 58.07%-112.92M | ---8.51M | 99.96%-97K | ---- | -1,849.88%-498.8M | ---269.3M |
-Less:Restructuring and merger&acquisition | ---- | 9,762.89%9.57M | ---- | ---- | ---- | ---- | --97K | ---- | ---- | ---- |
-Less:Impairment of capital assets | --0 | ---- | ---- | -77.36%112.91M | -58.98%110.46M | --2.45M | ---- | ---- | --498.8M | --269.3M |
-Write off | --0 | ---- | ---- | --8.52M | --2.46M | --6.06M | ---- | ---- | --0 | --0 |
Income before tax | 24.36%-35.18M | -107.41%-103.1M | 1.70%-52.3M | 56.00%-326.38M | 43.33%-176.96M | 22.70%-46.51M | 83.33%-49.71M | 25.28%-53.2M | -174.75%-741.84M | -358.69%-312.25M |
Income tax | 287.23%264K | 1,400.00%345K | 64.45%-198K | -107.28%-3.11M | -2,436.54%-2.43M | -123.58%-141K | 102.44%23K | 55.65%-557K | 94.95%-1.5M | -96.64%104K |
Net income | 23.56%-35.45M | -108.01%-103.44M | 1.03%-52.1M | 56.33%-323.27M | 44.12%-174.53M | 23.70%-46.37M | 83.27%-49.73M | 24.74%-52.64M | -208.05%-740.34M | -338.90%-312.35M |
Net income continuous Operations | 23.56%-35.45M | -108.01%-103.44M | 1.03%-52.1M | 56.33%-323.27M | 44.12%-174.53M | 23.70%-46.37M | 83.27%-49.73M | 24.74%-52.64M | -208.05%-740.34M | -338.90%-312.35M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 23.56%-35.45M | -108.01%-103.44M | 1.03%-52.1M | 56.33%-323.27M | 44.12%-174.53M | 23.70%-46.37M | 83.27%-49.73M | 24.74%-52.64M | -208.05%-740.34M | -338.90%-312.35M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 23.56%-35.45M | -108.01%-103.44M | 1.03%-52.1M | 56.33%-323.27M | 44.12%-174.53M | 23.70%-46.37M | 83.27%-49.73M | 24.74%-52.64M | -208.05%-740.34M | -338.90%-312.35M |
Basic earnings per share | 25.17%-1.07 | -101.94%-3.13 | 0.00%-1.6 | 57.45%-10 | 45.76%-5.37 | 24.74%-1.43 | 83.68%-1.55 | 27.27%-1.6 | -155.43%-23.5 | -296.00%-9.9 |
Diluted earnings per share | 25.17%-1.07 | -101.94%-3.13 | 0.00%-1.6 | 57.45%-10 | 45.76%-5.37 | 24.74%-1.43 | 83.68%-1.55 | 27.27%-1.6 | -155.43%-23.5 | -296.00%-9.9 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |